Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial

Deepak Cyril D’Souza, Patrick D. Skosnik, Gina Creatura et al.|The Lancet Psychiatry|2018

Cited by 194